Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT02211443. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Development of Dermatology-related Quality of Life Assessment in Patients Treated With Epidermal Growth Factor Receptor (EGFR) Inhibitors
ClinicalTrials.gov study NCT01015326. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prophylactic TCM for Mitigation of EGFR-TKI Related Dermatological Adverse Effect
ClinicalTrials.gov study NCT05204758. IPD Sharing: NO. Countries: 0. Publications: 6.
G1T38, a CDK 4/6 Inhibitor, in Combination With Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT03455829. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy
ClinicalTrials.gov study NCT00083720. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Study of ASP2215 in Combination With Erlotinib in Subjects With Epidermal Growth Factor Receptor (EGFR) Activating Mutation-Positive (EGFRm+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Who Have Acq
ClinicalTrials.gov study NCT02495233. IPD Sharing: NO. Countries: 1. Publications: 0.
Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M
ClinicalTrials.gov study NCT02972333. IPD Sharing: NO. Countries: 0. Publications: 1.
HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04676477. IPD Sharing: YES. Countries: 4. Publications: 0.
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
ClinicalTrials.gov study NCT04410796. IPD Sharing: YES. Countries: 1. Publications: 0.
RAS Mutations in ctDNA and Anti-EGFR reINTROduction in mCRC (RASINTRO)
ClinicalTrials.gov study NCT03259009. IPD Sharing: Not stated. Countries: 0. Publications: 12.
Testing AZD9291 as Potentially Targeted Treatment in Cancers With EGFR Genetic Changes (MATCH-Subprotocol E)
ClinicalTrials.gov study NCT06303167. IPD Sharing: YES. Countries: 1. Publications: 0.
Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy
ClinicalTrials.gov study NCT00503685. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck
ClinicalTrials.gov study NCT02979977. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations
ClinicalTrials.gov study NCT01646125. IPD Sharing: Not stated. Countries: 12. Publications: 0.
The Relation Between Thyroid , Parathyroid Hormones and eGFR in CKD Patients in Assiut
ClinicalTrials.gov study NCT05243979. IPD Sharing: Not stated. Countries: 0. Publications: 8.
TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR-mutant/Metastatic NSCLC Who Have Not Had Any Previous EGFR Directed Therapy
ClinicalTrials.gov study NCT02186301. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Endostar Plus EGFR-TKI（Epidermal Growth Factor Receptor-Tyrosine-Kinase Inhibitor） as a Treatment of EGFR Mutation-positive NSCLC
ClinicalTrials.gov study NCT03008109. IPD Sharing: Not stated. Countries: 0. Publications: 1.
β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC
ClinicalTrials.gov study NCT03123484. IPD Sharing: UNDECIDED. Countries: 0. Publications: 5.
Kidney Damage in Patients With Moderate Fall in eGFR
ClinicalTrials.gov study NCT01136876. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation
ClinicalTrials.gov study NCT02208843. IPD Sharing: Not stated. Countries: 7. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.